Del. Jury Clears Teva In $41M Orexo Drug Patent Suit
A Teva Pharmaceuticals Ltd. subsidiary did not infringe Orexo AB's opioid addiction treatment drug Zubsolv with two generic drugs, a Delaware federal jury ruled Friday, after a five-day trial over Orexo's...To view the full article, register now.
Already a subscriber? Click here to view full article